Enhanced and controlled chromatin extraction from FFPE tissues and the application to ChIP-seq
Authors:
- Jian ZhongJZJian Zhong
- Zhenqing YeZYZhenqing Ye
- Chad R. ClarkCCChad R. Clark
- Samuel W. LenzSLSamuel W. Lenz
- Justin H. NguyenJNJustin H. Nguyen
- Huihuang YanHYHuihuang Yan
- Keith D. RobertsonKRKeith D. Robertson
- Gianrico FarrugiaGFGianrico Farrugia
- Zhiguo ZhangZZZhiguo Zhang
- Tamas OrdogTOTamas Ordog
- Jeong-Heon LeeJLJeong-Heon Lee
Open Access
- 29 March 2019
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 20 (1) , 249
Abstract
Epigenetic dysregulation is involved in the etiology and progression of various human diseases. Formalin-fixed paraffin-embedded (FFPE) samples represent the gold standard for archiving pathology samples, and thus FFPE samples are a major resource of samples in clinical research. However, chromatin-based epigenetic assays in the clinical settings are limited to fresh or frozen samples, and are hampered by low chromatin yield in FFPE samples due to the lack of a reliable and efficient chromatin preparation method. Here, we introduce a new chromatin extraction method from FFPE tissues (Chrom-EX PE) for chromatin-based epigenetic assays. During rehydration of FFPE tissues, applying a tissue-level cross-link reversal into the deparaffinized tissue at 65 °C dramatically increased chromatin yield in the soluble fraction. The resulting chromatin is compatible with targeted ChIP-qPCR and genome-wide ChIP-seq approaches. The chromatin prepared by Chrom-EX PE showed a gradual fragmentation pattern with varying incubation temperature. At temperatures below 37 °C, the majority of soluble chromatin is over 1 kb. The soluble chromatin prepared in the range of 45–60 °C showed a typical nucleosomal pattern. And the majority of chromatin prepared at 65 °C is close to mononucleosomal size. These observations indicate that chromatin preparation from FFPE samples can be controlled for downstream chromatin-based epigenetic assays. This study provided a new method that achieves efficient extraction of high-quality chromatin suitable for chromatin-based epigenetic assays with less damage on chromatin. This approach may provide a way to circumvent the over-fixed nature of FFPE tissues for future technology development.Keywords
Funding Information
- National Institutes of Health (P01DK068055, P01DK068055, P01DK068055)
This publication has 24 references indexed in Scilit:
- Epigenomic profiling of archived FFPE tissues by enhanced PAT-ChIP (EPAT-ChIP) technologyClinical Epigenetics, 2018
- ChIP-seq in Studying Epigenetic Mechanisms of Disease and Promoting Precision Medicine: Progresses and Future DirectionsEpigenomics, 2016
- Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profilesNature Medicine, 2016
- Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samplesNature, 2015
- Diverse Epigenetic Mechanisms of Human DiseaseAnnual Review of Genetics, 2014
- PAT-ChIP coupled with laser microdissection allows the study of chromatin in selected cell populations from paraffin-embedded patient samplesEpigenetics & Chromatin, 2014
- Chromatin immunoprecipitation and high-throughput sequencing from paraffin-embedded pathology tissueNature Protocols, 2011
- Use of Formalin-Fixed and Paraffin-Embedded Tissues for Diagnosis and Therapy in Routine Clinical Settings2011
- Pathology tissue–chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samplesProceedings of the National Academy of Sciences, 2010
- Epigenetic modifications and human diseaseNature Biotechnology, 2010